Tag: weight loss

Medicare Struggles to Expand Diabetes Prevention Program

Damon Diessner tried for years to slim down from his weight of more than 400 pounds, partly because his size embarrassed his wife but even...

Medicare Proposes Direct Payments to PAs, Telehealth Expansion

Medicare intends next year to allow physician assistants (PAs) to begin directly billing for their work and to expand coverage of telehealth services. It also...

Managing Early Complications After Bariatric/Metabolic Surgery

The American Gastroenterological Association recently published a clinical practice update concerning endoscopic evaluation and management of early complications after bariatric/metabolic surgery. The seven best practice...

Can Overweight Docs Really Give Credible Weight Loss Advice?

July 7, 2021 — Kevin Gendreau, MD, a weight loss doctor at Southcoast Health in Fall River, MA, lets patients know that he was...

Insulin-Pramlintide Combo Improves Type 1 Diabetes Control

A novel investigational coformulation of prandial insulin and pramlintide improves blood glucose control and reduces body weight in people with type 1 diabetes, early research...

Novel Colonic Agonist Formulation Promising for Obesity

NEW YORK (Reuters Health) – A colonic release formulation of medium-chain fatty acids (MFCA) curbed appetite and boosted levels of the anorexigenic hormone PYY in...

Digital Diabetes Coaching Systems: Too Expensive or Worthwhile?

Dr Anne L. Peters Digital coaching systems for type 2 diabetes “reduce the need for more expensive, in-person visits,” said Anne L. Peters, MD, arguing...

‘Stunning’ Twincretin Beats Semaglutide in Type 2 Diabetes

Tirzepatide, a novel “twincretin” agent, was superior to 1-mg semaglutide treatments for reducing both hemoglobin A1c levels and body weight in patients with type 2...

Time-Restricted Eating Is ‘Promising, But More Data Are Needed’

Time-restricted eating — that is, reducing the number of hours a person is allowed to eat during the day — may produce a modest 1%...

FDA Approves ‘Gamechanger’ Semaglutide for Weight Loss

The US Food and Drug Administration (FDA) has approved a 2.4 mg/week subcutaneous dose of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy, Novo Nordisk)...

Weight Gain Does Not Protect Cognition

In contrast to previous research, a new study suggests that weight gain in older adults does not preserve cognition — and may actually be detrimental....

Diabetes, Weight Loss Drug Works Better With Exercise

By Amy Norton HealthDay Reporter THURSDAY, May 6, 2021 (HealthDay News) — The weight-loss drug Saxenda can keep extra pounds off — but combining it...

Some NP Thyroid Lots Recalled Due to Reduced Potency

In its third voluntary recall in the past year, Acella Pharmaceuticals has announced a nationwide recall of specific lots of its popular hypothyroid treatment NP Thyroid...

Bariatric Surgery May Cut Cancer in Obesity With Liver Disease

In a large cohort of insured working adults with severe obesity and nonalcoholic fatty liver disease (NAFLD), among those who underwent bariatric surgery, the rate of...

Mark’s Accomplishing More Than He Thought He Could

This post appears as part of our Healthier 2021 series, in which we follow three WebMD team members as they strive to improve their...

Healthier 2021: Bill Found New Motivation

This post appears as part of our Healthier 2021 series, in which we follow three WebMD team members as they strive to improve their...

Psychiatrists’ Happiness, Well-Being Hit Hard by COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Events of the past year have taken a huge toll on...

Healthier 2021: Mark Celebrates Small Victories

This post appears as part of our Healthier 2021 series, in which we follow three WebMD team members as they strive to improve their...

Bill’s Using His Scale and Food Log to Keep Him on Track

This post appears as part of our Healthier 2021 series, in which we follow three WebMD team members as they strive to improve their...

Mark Is Facing His Feelings

This post appears as part of our Healthier 2021 series, in which we follow three WebMD team members as they strive to improve their...

Semaglutide for Weight Loss? A Good First STEP, With Caveats

The phase 3a STEP 1 trial that investigated the use of semaglutide (Novo Nordisk), a glucagon-like peptide-1 (GLP-1) agonist, for weight loss is aptly named,...

Bill Is Accepting That His Fitness Is No Longer What It Was

This post appears as part of our Healthier 2021 series, in which we follow three WebMD team members as they strive to improve their...

Bill’s Journey Takes an Unexpected Turn

This post appears as part of our Healthier 2021 series, in which we follow three WebMD team members as they strive to improve their...

Exercise Doesn’t Boost Health If You Stay Obese

FRIDAY, Jan. 22, 2021 (HealthDay News) — The harmful effects of obesity on the heart can’t be undone by exercise, and it’s not possible to...

Bill Is Staying on Track, Even While Traveling

This post appears as part of our Healthier 2021 series, in which we follow three WebMD team members as they strive to improve their...